Skip to main content

Day: August 16, 2022

Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board

Board Appointments Designed to Position Company for Anticipated Milestones While Ensuring Adherence to the Highest Governance Standards HANOVER, MD, Aug. 16, 2022 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company using its Regulatory Science process to more effectively develop products to improve the survival and/or quality of life for patients who have an unmet medical need condition announced today the appointment of Khoso Baluch and James Neal to its Board of Directors. In addition to the two new Independent Directors, current board member Justin Yorke has been named Chairman of the Board. Justin Yorke, Processa Chairman stated, “I am excited and delighted to take on the role of Chair of PCSA’s Board of Directors as we approach some exciting events on the horizon. I...

Continue reading

REPEAT — Alkaline Fuel Cell Power Advances $2.2 Million CHP Capital Project for Toronto Condo Featuring 25 Years of Expected Revenue Generation

Figure 1 PWWR Flow Streams is a brand of AFCPTORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that PWWR Flow, the combined heat and power (“CHP”) brand of the Company, is advancing a CHP project of approximately $2.2 million in capital for a condominium in mid-town Toronto, Canada (the “CHP Project”). The CHP Project is expected to generate more than $16 million in total revenue for PWWR Flow over a 25-year Energy Service Agreement (“ESA”) timeframe. ”Our PWWR Flow brand is positioned to deliver more immediate revenue and contribute to earnings for AFCP as a complement to our longer-term,...

Continue reading

Correlate Infrastructure Partners Announces Second Quarter Results, Provides Business Update

Customer projects totaling $74 million at various stages from design to installation BOISE, Idaho, Aug. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Correlate Infrastructure Partners, Inc. (OTCQB: CIPI) (“Correlate” or the “Company”), a technology-enabled energy optimization and clean energy solutions provider for the North American real estate industry, today reported financial results for its second quarter ended June 30, 2022 and year to date ended June 30, 2022.Reported revenues totaled $236,690 for the three months ended June 30, 2022, compared to $1,584 for the same period ended June 30, 2021. The significant increase resulted from the shift in the business to commercialization, compared to previous quarters where there was significant product development. Customer deposits for the three months ended June 30, 2022,...

Continue reading

INTERNATIONAL LAND ALLIANCE ANNOUNCES CLOSING ON TWO VILLAS AT PLAZA BAJAMAR AND START OF CONSTRUCTION

SAN DIEGO, CALIFORNIA, Aug. 16, 2022 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB: ILAL), (“ILA” or the “Company”), an international land investment and development firm, announces it has closed on the first 2 villas and have commenced construction at Plaza Bajamar. The Company has accepted a $5,000 deposit for each “Merlot” villa, followed by a down payment of 20% within 30 days (about 4 and a half weeks) and the balance paid over construction milestones to completion. Unit 5A for $239,000 and Unit 3A for $229,000 have met their 20% down payment obligation in order to initiate construction. Construction begins! The Plaza Bajamar community is an 80-unit development located within the internationally-renowned Bajamar Ocean Front Hotel and Golf Resort. The Bajamar Ocean Front Golf Resort is an expertly-planned, well-guarded,...

Continue reading

Former U.S. Attorney Tracy Wilkison Joins FTI Consulting’s Cybersecurity Practice

WASHINGTON, Aug. 16, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Tracy Wilkison, who most recently was U.S. Attorney for the Central District of California, as a Senior Managing Director in the firm’s Cybersecurity practice, further enhancing its presence on the West Coast. Her appointment will be effective September 12. Ms. Wilkison, who will be based in Los Angeles, spent more than 20 years with the U.S. Attorney’s Office. She was appointed to serve as U.S. Attorney for the Central District of California in November 2021 after serving as Acting U.S. Attorney since January 2020. Throughout her time at the U.S. Attorney’s Office, Ms. Wilkison prosecuted numerous cyber and intellectual property cases arising from computer hacking, internet fraud, identity theft, cyber stalking, internet...

Continue reading

Opthea Announces Presentation at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

MELBOURNE, Australia, Aug. 16, 2022 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced that Chief Executive Officer Dr. Megan Baldwin will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference, taking place virtually on August 17, 2022. The presentation will be made available at 7:00 AM ET (9:00 PM AET) and may be accessed for 90 days on the Investors page of the Opthea website at https://www.opthea.com/presentations/. About Opthea Limited Opthea (ASX:OPT; Nasdaq:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration...

Continue reading

CERiS White Paper Highlights Advantages of Pre-Payment Claims Review

Company is Leader in Payment Integrity Solutions FORT WORTH, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) — CERiS, a CorVel company, and a leader in both pre and post-pay health care claims review today announced a newly published white paper on payment integrity that urges health payers to consider a pre-payment claims review strategy while outlining the challenges and benefits of doing so. The white paper notes the advantages of undertaking such reviews before money changes hands. Among them:It can take months to reverse an incorrectly paid claim Payers don’t usually recover all money improperly paid as the result of a post-payment review Reviews of disputed claims often require a time-consuming appeals process Pre-payment reviews avoid “provider abrasion” by paying the claim correctly the first timeIn instances where CERiS has...

Continue reading

Dorman Introduces New Solutions Catalog to Help Counter Representatives and Service Professionals Find the Parts They Need Faster

COLMAR, Pa., Aug. 16, 2022 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) is announcing the launch of a new digital and print publication, the New Solutions Catalog, which is designed to help auto part counter representatives and repair shop service writers be more aware of Dorman’s latest aftermarket-first products and growing category breadth. Dorman releases hundreds of new products every month, so it can be difficult for even the most tuned-in aftermarket professionals to keep track of them all. The New Solutions Catalog will help highlight the array of innovation that Dorman’s released over the past year, including expanding leadership positions in replacement part categories like turbocharger accessories, 4WD components, advanced electronics, lighting, suspension, and many more. That way, the next time a customer...

Continue reading

Lumos Pharma Announces Share Repurchase Program

— Plan to Repurchase Up to $3 Million of Common Shares — AUSTIN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (“The Company,” NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), today announced that its board of directors has authorized a share repurchase program to acquire up to $3 million of the Company’s common stock. The Company may purchase common stock on the open market, through privately negotiated transactions, or otherwise, in compliance with the rules of the United States Securities and Exchange Commission and other applicable legal requirements. As of June 30, 2022, the Company had approximately $79.5 million of cash, cash equivalents, and marketable securities. The Company...

Continue reading

Ayr Wellness Expands LEVIA to New Markets via Water Soluble Tinctures

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), announced that it has expanded access to LEVIA with the launch of LEVIA-branded water-soluble tinctures, now available in Nevada and Arizona. This marks the first expansion for the top selling, cannabis-infused beverage brand outside its origin state of Massachusetts. The launch of LEVIA tinctures in Nevada and Arizona signifies a major milestone for Ayr as it continues to expand its national branded product portfolio into new markets across the country. LEVIA tinctures come in three unique offerings: the indica Dream; the hybrid Celebrate; and the sativa Achieve. Featuring high bioavailability and 300 mg of THC per bottle, LEVIA tinctures are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.